Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | MGAM | O43451 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SI | P14410 | 1/20 | 0.38 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 6/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrrole SCHEMBL22498567 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRHSD17B10LMNA | |
| Pyrrole SCHEMBL27698174 | 0.83 | TSHR (0.37) | ALDH1A1MGAMGAASIMGAM2 | |
| Pyrrole SCHEMBL9400676 | 0.83 | TSHR (0.35) | ALDH1A1MGAMGAASIMGAM2 | |
| Pyrrole SCHEMBL3807182 | 0.82 | — | — | |
| Pyrrole SCHEMBL311019 | 0.79 | — | — | |
| Acetic Acid SCHEMBL27669193 | 0.79 | FFAR3 (0.47) | ALDH1A1TSHRHSD17B10LMNA | |
| Benzene SCHEMBL2869929 | 0.78 | ALDH1A1 (0.77) | ALDH1A1MGAMGAASIMGAM2 | |
| Pyrrole SCHEMBL28065784 | 0.77 | FFAR3 (0.44) | ALDH1A1LMNA | |
| Pyrrole SCHEMBL9980539 | 0.77 | — | — | |
| Benzene SCHEMBL27466044 | 0.76 | ALDH1A1 (0.71) | ALDH1A1MGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113023678-B | Oxygen generation device of high-temperature carbonized ceramic-based molecular sieve membrane and use method thereof | 湖南万脉医疗科技有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-113023679-A | Oxygen generation device of medical high-temperature molecular sieve membrane adsorption tower and use method thereof | 湖南万脉医疗科技有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-113023678-A | Oxygen generation device of high-temperature carbonized ceramic-based molecular sieve membrane and use method thereof | 湖南万脉医疗科技有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-113023679-B | Oxygen generation device of medical high-temperature molecular sieve membrane adsorption tower and use method thereof | 湖南万脉医疗科技有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-113023678-B | Oxygen generation device of high-temperature carbonized ceramic-based molecular sieve membrane and use method thereof | 湖南万脉医疗科技有限公司 | 2022-03-18 | — | — | CN | disclosed |
| CN-113023678-A | Oxygen generation device of high-temperature carbonized ceramic-based molecular sieve membrane and use method thereof | 湖南万脉医疗科技有限公司 | 2021-06-25 | — | — | CN | disclosed |
| CN-113023679-A | Oxygen generation device of medical high-temperature molecular sieve membrane adsorption tower and use method thereof | 湖南万脉医疗科技有限公司 | 2021-06-25 | — | — | CN | disclosed |
| US-6255490-B1 | TREATING DISORDERS ASSOCIATED WITH CHANGES IN CHOLINERGIC ACTIVITY; NON-OPIATE BASED ANALGESIC FOR MODERATE TO SEVERE PAIN EQUALLY OR EXCEEDING THE POTENCY OF OPIATE ANALGESICS, YET LACKING ADDICTIVE SIDE EFFECTS | UNIVERSITY OF VIRGINIA | 2001-07-03 | — | — | US | disclosed |
| US-6117889-A | 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents | UNIVERSITY OF VIRGINIA (US) | 2000-09-12 | — | — | US | disclosed |
| US-6060473-A | 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands | UCB S.A. - DTB (BE) | 2000-05-09 | — | — | US | disclosed |
| EP-0778835-A4 | 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS | UNIV VIRGINIA (US) | 1999-02-03 | — | — | EP | disclosed |
| EP-0778835-A1 | 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS | UNIVERSITY OF VIRGINIA (US) | 1997-06-18 | — | — | EP | disclosed |
| WO-1996006093-A1 | 7-AZABICYCLO[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS | UNIVERSITY OF VIRGINIA (US) | 1996-02-29 | — | — | WO | disclosed |
| EP-0691971-A1 | 7-AZABICYCLO- 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS ANALGESICS AND ANTI-INFLAMMATORY AGENTS | UNIVERSITY OF VIRGINIA (US) | 1996-01-17 | — | — | EP | disclosed |
| WO-1994022868-A1 | 7-AZABICYCLO-[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS ANALGESICS AND ANTI-INFLAMMATORY AGENTS | UNIVERSITY OF VIRGINIA (US) | 1994-10-13 | — | — | WO | disclosed |